L-norvaline; (S)-2-Aminopentanoic acid; h-nva-oh; (2S)-2-aminopentanoic acid; L-2-aminopentanoic acid; L-2-Aminovaleric acid; (S)-2-Aminovaleric acid; UNII-A70UKS48FE; 2-Aminovaleric acid; Norvaline, L-; l-(+)-norvaline; 2S-amino-pentanoic acid; MFCD00064421; A70UKS48FE; Valeric acid, 2-amino-; Pentanoic acid, 2-amino-; L(+)-Norvaline, 99%; L(+)-Norvaline; 2-AMINO-PENTANOIC ACID; Norvaline (VAN); L-2-aminopentanoic acid zwitterion; alpha-L-Aminopentanoic acid; norvalin; Pentanoic acid, 2-amino-, (S)-; EINECS 229-543-3; NSC 203786; PubChem5727; L-Norvaline (9CI); SCHEMBL38405; (S)-2-amino-pentanoic acid; (2S)-2-azanylpentanoic acid; CHEMBL55612; L-Norvaline, arginase inhibitor; CTK2F3175; KS-00000AAU; DTXSID701018015; ZINC391821; CS-D1371; HY-Y0399; KS-00000A8O; ANW-35129; BDBM50357215; LMFA01100041; AKOS006240270; AB02603; DB04185; LS30304; AC-12879; AC-31149; AS-13576; BR-44188; SC-06139; AB0013881; AM20100599; N0686; C01826; M-3555; N-9040; 33778-EP2275102A1; 33778-EP2277865A1; 33778-EP2277867A2; 33778-EP2280003A2; 33778-EP2295055A2; 33778-EP2311453A1; 178647-EP2270002A1; 600N404; A835303; Q418707; Z1741968246; UNII-V639KTF2SZ component SNDPXSYFESPGGJ-BYPYZUCNSA-N; 9555A1CC-4DD7-41F1-9133-98A0F33A16A6